A randomised, prospective and head-to-head comparison of [68ga]ga-psma-11 and [18f]psma-1007 for the detection of recurrent prostate cancer in psma-ligand pet/ct—protocol design and rationale

HIGHLIGHTS

• who: Ian Alberts and colleagues from the Department of Nuclear Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, CTU Bern, Mittelstrasse, Bern, Switzerland have published the research: A randomised, prospective and head-to-head comparison of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007 for the detection of recurrent prostate cancer in PSMA-ligand PET/CTu2014Protocol design and rationale, in the Journal: PLOS ONE of April/29,/2022
• what: The aim of this trial is to establish the non-inferiority of the new radiopharmaceutical in terms of the rate of PETpositive findings and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.